Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies
Atopic dermatitis (AD) is a chronic inflammatory skin disease often requiring systemic therapies for moderate-to-severe cases. Janus kinase (JAK) inhibitors, including upadacitinib, have emerged as effective options, targeting pro-inflammatory cytokines involved in AD pathogenesis. However, adverse...
Saved in:
| Main Authors: | Claudia Paganini, Edoardo Mortato, Lorenzo Tofani, Alfredo Belcastro, Marina Talamonti, Cosimo Di Raimondo, Luca Bianchi, Marco Galluzzo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2025-03-01
|
| Series: | Dermatology Reports |
| Subjects: | |
| Online Access: | https://www.pagepress.org/journals/dr/article/view/10193 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
by: Edoardo Mortato, et al.
Published: (2025-12-01) -
Experience of using the drug upadacitinib in a child with severe atopic dermatitis
by: G. D. Alemanova, et al.
Published: (2025-06-01) -
Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry
by: Barbara Kind, et al.
Published: (2025-05-01) -
A Case of Upadacitinib-Associated Ileus Secondary to Psoriasis Induced by Treatment of Atopic Dermatitis with Dupilumab
by: Liu X, et al.
Published: (2024-12-01) -
Upadacitinib in daily practice for refractory atopic dermatitis in adolescents: a case series of the BioDay registry
by: Florence Vroman, et al.
Published: (2025-12-01)